Medicover Hospitals has conducted a study on the safety and efficacy of Covid vaccines, Covaxin and Covishield.
“We have done a detailed review and analysis of the adverse effects and the outcomes of vaccination among the healthcare workers (Medicover staff) and also among the frontline workers including police. Sample size is about 12,000 people,” they said.
As the results came in, 13 percent of people were infected (out of which 2.63 percent of people got admitted) after the 1st dosage, and 2.83 percent were infected after the 2nd dosage (out of which 0.4 percent got admitted)
All the infections are of in mild the category and none of them were turned to the moderate/severe category.
No deaths were reported and no case is reported with any clotting issues
“Our motto behind the study is to put a evidence-based study in front of the people to avoid the hesitancy towards covid vaccination and also to avoid the confusion regarding the brand of vaccine”, Sharat Reddy, Executive Director of Clinical Services Medicover hospitals India said.
“Healthcare and frontline category of workers are in enormous exposure to the disease, so if we can see this kind of result in them we can excellent results in public and we can definitely break the chain of this pandemic,” Reddy added.
